US 11447797
AAV with unique capsid protein VP1 and methods of using for treatment
granted A61PA61P5/14
Quick answer
US patent 11447797 (AAV with unique capsid protein VP1 and methods of using for treatment) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Sep 20 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61P, A61P5/14